| Financial Year |
March 31 2023 |
| Monetary Funds |
5,385,866,420.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
181,083,303.90 |
| Accounts Receivable |
890,086,718.60 |
| Advances to Suppliers |
38,293,609.68 |
| Other Receivables |
9,825,273.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
506,551,296.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
95,166,301.02 |
| Total Current Assets |
7,113,819,953.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
75,844,929.20 |
| Fixed Assetes |
722,294,018.52 |
| Under-construction Projects |
472,518,383.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
288,383,107.17 |
| R&D expenses |
95,341,547.13 |
| Goodwill |
321,396,801.20 |
| Long-Term Deferred and Prepaid Expenses |
8,490,645.53 |
| Deferred Income Tax Assets |
23,777,381.26 |
| Other Non-Current Assets |
41,695,362.35 |
| Sub-Total of Non-Current Assets |
2,066,767,837.94 |
| Total Assets |
9,180,587,791.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
377,205,249.75 |
| Accounts Received In Advance |
2,351,901.55 |
| Employee Compensation Payable |
38,032,131.54 |
| Taxes Payable |
78,087,841.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,948,968.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,848,199.87 |
| Other Current Liabilities |
42,485,380.92 |
| Sub-Total of Current Liabilities |
595,123,574.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,360,212.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
255,200,062.42 |
| Total Liabilities |
850,323,636.55 |
| Paid-In Capital(Or Share Stock) |
2,154,587,862.00 |
| Capital Surplus |
5,050,886,993.00 |
| Surplus Reserve |
126,635,307.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,005,560,011.23 |
| Minority Stockholder's Interest |
-7,406,018.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,337,670,173.39 |
| Owner's Equity（Stockholder's Equity） |
8,330,264,154.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,180,587,791.36 |
